Pure Biologics Spólka Akcyjna (PUR) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.011x

Based on the latest financial reports, Pure Biologics Spólka Akcyjna (PUR) has a cash flow conversion efficiency ratio of 0.011x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (zł-216.00K ≈ $-59.45K USD) by net assets (zł-19.39 Million ≈ $-5.34 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See defensive interval ratio of Pure Biologics Spólka Akcyjna to measure how many days the company can operate on defensive assets alone.

Pure Biologics Spólka Akcyjna - Cash Flow Conversion Efficiency Trend (2016–2024)

This chart illustrates how Pure Biologics Spólka Akcyjna's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Pure Biologics Spólka Akcyjna Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Pure Biologics Spólka Akcyjna ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Bayan Mining and Minerals Ltd AU:BMM	-0.112x
Hantop Inc KQ:002680	0.055x
Worksport Ltd NASDAQ:WKSP	-0.412x
VerifyMe Inc NASDAQ:VRME	0.005x
T4F Entretenimento S.A SA:SHOW3	0.208x
Emerson Radio Corporation NYSE MKT:MSN	-0.106x
SunLink Health Systems Inc NYSE MKT:SSY	-0.190x
Addex Therapeutics Ltd NASDAQ:ADXN	-0.128x

Annual Cash Flow Conversion Efficiency for Pure Biologics Spólka Akcyjna (2016–2024)

The table below shows the annual cash flow conversion efficiency of Pure Biologics Spólka Akcyjna from 2016 to 2024. For the full company profile with market capitalisation and key ratios, see Pure Biologics Spólka Akcyjna market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	zł-13.12 Million ≈ $-3.61 Million	zł-10.83 Million ≈ $-2.98 Million	0.826x	+106.72%
2023-12-31	zł1.89 Million ≈ $520.98K	zł-23.26 Million ≈ $-6.40 Million	-12.288x	-1193.16%
2022-12-31	zł18.30 Million ≈ $5.04 Million	zł-17.39 Million ≈ $-4.79 Million	-0.950x	-56.11%
2021-12-31	zł39.49 Million ≈ $10.87 Million	zł-24.04 Million ≈ $-6.61 Million	-0.609x	-229.88%
2020-12-31	zł-2.89 Million ≈ $-794.54K	zł-1.35 Million ≈ $-372.37K	0.469x	-36.63%
2019-12-31	zł7.21 Million ≈ $1.99 Million	zł5.33 Million ≈ $1.47 Million	0.740x	+166.02%
2018-12-31	zł2.22 Million ≈ $611.22K	zł-2.49 Million ≈ $-684.71K	-1.120x	+91.75%
2017-12-31	zł209.77K ≈ $57.73K	zł-2.85 Million ≈ $-784.16K	-13.583x	-496.09%
2016-12-31	zł311.70K ≈ $85.78K	zł-710.24K ≈ $-195.47K	-2.279x	--

About Pure Biologics Spólka Akcyjna

WAR:PUR Poland Biotechnology

Market Cap

$7.86 Million

zł28.55 Million PLN

Market Cap Rank

#27611 Global

#306 in Poland

Share Price

zł2.52

Change (1 day)

+9.80%

52-Week Range

zł1.42 - zł8.25

All Time High

zł142.00